Home » Stocks » MDT

Medtronic plc. (MDT)

Stock Price: $128.28 USD 2.15 (1.70%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
After-hours: $128.75 +0.47 (0.37%) Apr 20, 7:37 PM
Market Cap 172.71B
Revenue (ttm) 27.93B
Net Income (ttm) 2.89B
Shares Out 1.35B
EPS (ttm) 2.26
PE Ratio 56.79
Forward PE 22.32
Dividend $2.28
Dividend Yield 1.78%
Trading Day April 20
Last Price $128.28
Previous Close $126.13
Change ($) 2.15
Change (%) 1.70%
Day's Open 125.91
Day's Range 125.79 - 128.42
Day's Volume 5,411,114
52-Week Range 86.32 - 128.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

IN.PACT AV Access Trial 24 Month Results Presented as a Podium First at Charing Cross Symposium DUBLIN and LONDON, April 20, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical t...

9 hours ago - PRNewsWire

Edina, MN, based Investment company Accredited Investors Inc. (Current Portfolio) buys BTC iShares MSCI EAFE Value ETF, iShares Russell 2000 Value ETF, iShares MSCI All Country Asia ex Japan Index Fund,...

Other stocks mentioned: AAXJ, EFV, SPY, TGT, TSLA, VT
4 days ago - GuruFocus

If you think cyberattacks are scary, what if those attacks were directed at your cardiac pacemaker? Medtronic, a medical device company, has been in hot water over the last couple of years because its p...

4 days ago - TechCrunch

Medtronic's (MDT) recently introduced Medtronic Extended infusion set with longer wearability enhances convenience and comfort, thus improving diabetes care.

5 days ago - Zacks Investment Research

The new Micra AV leadless pacemaker proves that good things come in small packages.

5 days ago - The Motley Fool

DUBLIN, April 14, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first a...

6 days ago - PRNewsWire

These 3D stocks have proven to be instrumental in improving the quality of healthcare outcomes The post 3 3D Stocks That Can Advance the World of Healthcare appeared first on InvestorPlace. More From In...

Other stocks mentioned: OFIX, SSYS
1 week ago - InvestorPlace

Medtronic's (MDT) GI Genius Module is the only commercially available computer-aided detection system which uses artificial intelligence to identify colorectal polyploid.

1 week ago - Zacks Investment Research

- The GI Genius™ Module Assists Physicians in Detecting Pre-Cancerous Growths; Potentially Addressing 19 Million Colonoscopies Annually - Transformative AI Colorectal Cancer Prevention  Platform Expands...

1 week ago - PRNewsWire

Medtronic's (MDT) ventilator sales are robust and prospects of the Diabetes arm remain strong amid the pandemic.

1 week ago - Zacks Investment Research

MINNEAPOLIS, April 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diab...

1 week ago - PRNewsWire

Final Trades: Hanesbrands, Norwegian Cruise Line, Medtronic & more

YouTube video

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: HBI, NCLH
2 weeks ago - CNBC Television

Investors continue to be optimistic about Medtronic (MDT) on its slew of product launches and regulatory approvals.

2 weeks ago - Zacks Investment Research

This is a stable investment you can buy and forget about.

2 weeks ago - The Motley Fool

DUBLIN, March 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for its Harmony...

3 weeks ago - PRNewsWire

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

3 weeks ago - Zacks Investment Research

Medtronic looks attractive at current levels of $117, as it is up 60% from the levels it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks an underpe...

3 weeks ago - Forbes

This SenSight system according to Medtronic (MDT), is set to enhance detection of local field potentials (LFPs).

Other stocks mentioned: DBSDY
4 weeks ago - Zacks Investment Research

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical te...

4 weeks ago - PRNewsWire

There are long-term implications to the coronavirus pandemic that the market is not appreciating.

Other stocks mentioned: AAPL, ABMD, AMZN, CVX, GILD, JNJ, MRNA ...
4 weeks ago - The Motley Fool

Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.

Other stocks mentioned: ABT, NVO, PODD, TNDM
1 month ago - Zacks Investment Research

Just like that, we are less than two weeks from the end of the first quarter. While it has been a very positive one for investors, the rise in interest rates has brought in much higher volatility and ha...

Other stocks mentioned: BLK, C, GS, NBIX
1 month ago - 24/7 Wall Street

This latest development is expected to contribute to Medtronic's (MDT) pain therapy business in the coming months.

1 month ago - Zacks Investment Research

We think that Medtronic currently is a better pick compared to Intuitive Surgical. MDT stock trades at about 5.7x trailing revenues, compared to around 18.5x for ISRG.

1 month ago - Forbes

DUBLIN, March 17, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial lab...

1 month ago - PRNewsWire

NEX: CHIP CALGARY, AB, March 12, 2021 /PRNewswire/ - Health Logic Interactive Inc. ("Health Logic" or the "Company") (NEX: CHIP), is pleased to announce the hiring of Mr. David Barthel, as the Chief Exe...

1 month ago - PRNewsWire

DUBLIN, March 8, 2021 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Friday, March 5, 2021, approved the fiscal year 2021 fourth quarter cash dividend of $0.58 per ordinary share...

1 month ago - PRNewsWire

The S&P 500 stocks saw their aggregate trailing 12-month real revenue per share increase at a compound annual growth rate of nearly 2% over the past five years. The share price of the benchmark index fo...

Other stocks mentioned: CB, GLNG
1 month ago - GuruFocus

These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.

Other stocks mentioned: ABT, JNJ, MASI
1 month ago - Zacks Investment Research

When the market is expensive and overbought like the current one is, it is very important to stay with companies that not only have solid earnings potential but also have upcoming catalysts that can hel...

Other stocks mentioned: BDX, DXCM
1 month ago - 24/7 Wall Street

Medtronic's (MDT) REVERSE analysis highlights the role played by CRT to slow the progression of HF, thus reinforcing the strong clinical evidence supporting CRT.

1 month ago - Zacks Investment Research

Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.

1 month ago - Zacks Investment Research

The latest back-to-back incidents will, undoubtedly, create a major drag in Medtronic's (MDT) VAD performance.

1 month ago - Zacks Investment Research

The FDA has classified another recall of Medtronic Plc's (NYSE: MDT) HeartWare HVAD ventricular assist device as a Class I event in light of the potential for serious harm. Medtronic is recalling 157 HV...

1 month ago - Benzinga

DUBLIN, March 2, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac resyn...

1 month ago - PRNewsWire

In Coronary, the ongoing issue related to the China drug-eluting stent national tender, Medtronic (MDT) is currently winning share globally.

1 month ago - Zacks Investment Research

Final Trades: ROKU, MDT, SONO & XHB

YouTube video

The Fast Money traders make their final trades of the week.

Other stocks mentioned: ROKU, SONO, XHB
1 month ago - CNBC Television

Medtronic (MDT) procedure volumes hurt by resurgence of COVID-19 cases despite increased demand for related diagnostics and therapies.

1 month ago - Zacks Investment Research

Medtronic CEO Geoff Martha on Q3 EPS beat, pipeline and more

YouTube video

Medtronic reported a quarterly profit above Wall Street estimates, helped in part by stronger demand for ventilators amid the pandemic. Medtronic CEO Geoff Martha joined Tuesday "Squawk on the Street" t...

1 month ago - CNBC Television

Medtronic (MDT) delivered earnings and revenue surprises of 12.17% and -0.03%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of Medtronic (NYSE:MDT) fell 0.2% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 10.42% over the past year to $1.29, which beat the es...

1 month ago - Benzinga

- Q3 Revenue of $7.8 Billion Increased 0.8% as Reported and Decreased 1.0% Organically - Q3 GAAP Diluted EPS of $0.94; Q3 Non-GAAP Diluted EPS of $1.29 DUBLIN, Feb. 23, 2021 /PRNewswire/ -- Medtronic pl...

1 month ago - PRNewsWire

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

Other stocks mentioned: BSX, COO, HOLX, LH, MASI, XRAY
1 month ago - Zacks Investment Research

Medtronic stock is scheduled to report its fiscal third-quarter results on Tuesday, February 23. We expect Medtronic to likely post revenues in-line, and earnings above the consensus estimates.

1 month ago - Forbes

Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week.

Other stocks mentioned: ABNB, DASH, DKNG, HD, NVDA, BBY, CRM ...
1 month ago - 24/7 Wall Street

Medtronic (MDT) expects this updated labeling with wider procedural options and shorter wait time to improve patient access to MRI exams and add more flexibility for MRI providers.

2 months ago - Zacks Investment Research

Health care companies may not be at the front of mind when thinking of stocks with dividends, but these three are winners. The post 3 High-Quality Health Care Companies With Recession-Proof Dividends ap...

Other stocks mentioned: BDX, BMY
2 months ago - InvestorPlace

Medtronic's (MDT) recent surgeries reach a milestone in the transformation of spine surgery as a result of increased accuracy and minimally invasive technique.

2 months ago - Zacks Investment Research

The FDA has approved expanded MRI labeling of Medtronic plc's (NYSE: MDT) InterStim II and InterStim Micro sacral neuromodulation (SNM) systems that use SureScan MRI leads. The updated MRI Guidelines al...

2 months ago - Benzinga

Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 months ago - Zacks Investment Research

About MDT

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX... [Read more...]

Industry
Medical Devices
Founded
1949
CEO
Geoffrey Martha
Employees
90,000
Stock Exchange
NYSE
Ticker Symbol
MDT
Full Company Profile

Financial Performance

In 2020, Medtronic's revenue was $28.91 billion, a decrease of -5.38% compared to the previous year's $30.56 billion. Earnings were $4.79 billion, an increase of 3.41%.

Financial Statements

Analyst Forecasts

According to 27 analysts, the average rating for Medtronic stock is "Buy." The 12-month stock price forecast is 134.31, which is an increase of 4.70% from the latest price.

Price Target
$134.31
(4.70% upside)
Analyst Consensus: Buy